Kenosha, Wisconsin, is poised for an economic revival, thanks to a groundbreaking $3 billion investment from pharmaceutical giant Eli Lilly.
This announcement comes just days after a high-stakes meeting at Mar-a-Lago between President-elect Donald Trump, his nominee for Secretary of Health and Human Services Robert F. Kennedy Jr., and top executives from major pharmaceutical companies, including Eli Lilly and Pfizer.
The meeting, which also included Trump’s incoming chief of staff Susie Wiles and representatives from the Pharmaceutical Research and Manufacturers of America (PhRMA), signals a potential realignment of U.S. health policy.
While the specifics remain under wraps, insiders suggest the discussions centered on finding cures for cancer, among other topics, according to Axios.
This development is being hailed as a masterstroke by Trump, who has long championed bringing jobs back to the U.S. and revamping the pharmaceutical industry to prioritize American innovation and production.
Eli Lilly’s decision to expand its Kenosha facility is being lauded by Trump supporters as a direct result of the strategic discussions in Mar-a-Lago.
According to the company’s press release, the $3 billion investment will not only enhance the production of injectable medicines but also create 750 high-paying jobs in Kenosha County.
The expansion will also generate more than 2,000 construction jobs, making it one of the largest economic boosts in the region’s history.
Hellbound and Down 